RxDoctor Payments Data

Margaret Graff, PA

Physician Assistant · Centennial, CONPI 1134571110

Payments from drug & device makers

$2,457in general payments, 2019–2025

Across 138 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$757
  • Biohaven Pharmaceutical Holding Company Ltd.$232
  • Lilly USA, LLC$168
  • Novo Nordisk$157
  • Eisai Inc.$131
  • Merck$108
  • plus $904 from 23 others

What the payments were for

  • Food & beverage$2,457100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,457 in reported general payments places this provider in the 85th percentile of 2,849 physician assistant providers in Colorado.

See all physician assistant providers in Colorado

Medicare billing

Part B allowed, 2024
$212,459
Medicare patients
200
Services billed
2,495

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban358$95,198
RexultiBrexpiprazole79$50,669
TrulicityDulaglutide31$29,643
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$21,922
JardianceEmpagliflozin67$19,544
OzempicSemaglutide17$17,524
MounjaroTirzepatide12$12,844
Aripiprazole82$9,995
XareltoRivaroxaban37$9,399
Tresiba Flextouch U-100Insulin Degludec64$8,119
EntrestoSacubitril/Valsartan20$6,885
Fiasp FlextouchInsulin Aspart (Niacinamide)22$6,589
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog54$6,041
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,635
OxycontinOxycodone Hcl23$5,276

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$19$50,66979 claims
Lilly USA, LLCTrulicity, Mounjaro$168$42,48743 claims
Boehringer IngelheimJardiance$65$19,54467 claims
Novo NordiskOzempic$157$17,52417 claims
Johnson & JohnsonXarelto$40$9,39937 claims
NovartisEntresto$23$6,88520 claims
MerckDulera$108$4,79813 claims
Astellas Pharma US IncMyrbetriq$37$4,65819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,849 physician assistant providers in Colorado.

Other physician assistant in Centennial

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →